View in EDS

Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.

Saved in:
Bibliographic Details
Title: Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.
Authors: Collier DA; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK., De Marco A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Ferreira IATM; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Meng B; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Datir RP; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK., Walls AC; Department of Biochemistry, University of Washington, Seattle, WA, USA., Kemp SA; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK., Bassi J; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Pinto D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Silacci-Fregni C; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Bianchi S; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Tortorici MA; Department of Biochemistry, University of Washington, Seattle, WA, USA., Bowen J; Department of Biochemistry, University of Washington, Seattle, WA, USA., Culap K; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Jaconi S; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Snell G; Vir Biotechnology, San Francisco, CA, USA., Pizzuto MS; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Pellanda AF; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland., Garzoni C; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland., Riva A; Division of Infectious Diseases, Luigi Sacco Hospital, University of Milan, Milan, Italy., Elmer A; NIHR Cambridge Clinical Research Facility, Cambridge, UK., Kingston N; NIHR Bioresource, Cambridge, UK., Graves B; NIHR Bioresource, Cambridge, UK., McCoy LE; Division of Infection and Immunity, University College London, London, UK., Smith KGC; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Bradley JR; Department of Medicine, University of Cambridge, Cambridge, UK.; NIHR Bioresource, Cambridge, UK., Temperton N; University of Kent, Canturbury, UK., Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK., Barcenas-Morales G; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.; Laboratorio de Inmunologia, UNAM, Cuautitlán, Mexico., Harvey W; Institute of Biodiversity, University of Glasgow, Glasgow, UK., Virgin HW; Vir Biotechnology, San Francisco, CA, USA., Lanzavecchia A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Piccoli L; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Doffinger R; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Wills M; Department of Medicine, University of Cambridge, Cambridge, UK., Veesler D; Department of Biochemistry, University of Washington, Seattle, WA, USA., Corti D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. dcorti@vir.bio., Gupta RK; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK. rkg20@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk.; University of KwaZulu Natal, Durban, South Africa. rkg20@cam.ac.uk.; Africa Health Research Institute, Durban, South Africa. rkg20@cam.ac.uk.; Department of Infectious Diseases, Cambridge University Hospitals NHS Trust, Cambridge, UK. rkg20@cam.ac.uk.
Corporate Authors: CITIID-NIHR BioResource COVID-19 Collaboration, COVID-19 Genomics UK (COG-UK) Consortium
Source: Nature [Nature] 2022 Aug; Vol. 608 (7922), pp. E24.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35864232
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Collier+DA%22">Collier DA</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22De+Marco+A%22">De Marco A</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ferreira+IATM%22">Ferreira IATM</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Meng+B%22">Meng B</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Datir+RP%22">Datir RP</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Walls+AC%22">Walls AC</searchLink>; Department of Biochemistry, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Kemp+SA%22">Kemp SA</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Bassi+J%22">Bassi J</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pinto+D%22">Pinto D</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Silacci-Fregni+C%22">Silacci-Fregni C</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bianchi+S%22">Bianchi S</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tortorici+MA%22">Tortorici MA</searchLink>; Department of Biochemistry, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Bowen+J%22">Bowen J</searchLink>; Department of Biochemistry, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Culap+K%22">Culap K</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jaconi+S%22">Jaconi S</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cameroni+E%22">Cameroni E</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Snell+G%22">Snell G</searchLink>; Vir Biotechnology, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pizzuto+MS%22">Pizzuto MS</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pellanda+AF%22">Pellanda AF</searchLink>; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Garzoni+C%22">Garzoni C</searchLink>; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Riva+A%22">Riva A</searchLink>; Division of Infectious Diseases, Luigi Sacco Hospital, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Elmer+A%22">Elmer A</searchLink>; NIHR Cambridge Clinical Research Facility, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Kingston+N%22">Kingston N</searchLink>; NIHR Bioresource, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Graves+B%22">Graves B</searchLink>; NIHR Bioresource, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22McCoy+LE%22">McCoy LE</searchLink>; Division of Infection and Immunity, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Smith+KGC%22">Smith KGC</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Bradley+JR%22">Bradley JR</searchLink>; Department of Medicine, University of Cambridge, Cambridge, UK.; NIHR Bioresource, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Temperton+N%22">Temperton N</searchLink>; University of Kent, Canturbury, UK.<br /><searchLink fieldCode="AU" term="%22Ceron-Gutierrez+L%22">Ceron-Gutierrez L</searchLink>; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Barcenas-Morales+G%22">Barcenas-Morales G</searchLink>; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.; Laboratorio de Inmunologia, UNAM, Cuautitlán, Mexico.<br /><searchLink fieldCode="AU" term="%22Harvey+W%22">Harvey W</searchLink>; Institute of Biodiversity, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Virgin+HW%22">Virgin HW</searchLink>; Vir Biotechnology, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lanzavecchia+A%22">Lanzavecchia A</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Piccoli+L%22">Piccoli L</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Doffinger+R%22">Doffinger R</searchLink>; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Wills+M%22">Wills M</searchLink>; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Veesler+D%22">Veesler D</searchLink>; Department of Biochemistry, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Corti+D%22">Corti D</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. dcorti@vir.bio.<br /><searchLink fieldCode="AU" term="%22Gupta+RK%22">Gupta RK</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK. rkg20@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk.; University of KwaZulu Natal, Durban, South Africa. rkg20@cam.ac.uk.; Africa Health Research Institute, Durban, South Africa. rkg20@cam.ac.uk.; Department of Infectious Diseases, Cambridge University Hospitals NHS Trust, Cambridge, UK. rkg20@cam.ac.uk.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22CITIID-NIHR+BioResource+COVID-19+Collaboration%22">CITIID-NIHR BioResource COVID-19 Collaboration</searchLink><br /><searchLink fieldCode="CA" term="%22COVID-19+Genomics+UK+%28COG-UK%29+Consortium%22">COVID-19 Genomics UK (COG-UK) Consortium</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220410462%22">Nature</searchLink> [Nature] 2022 Aug; Vol. 608 (7922), pp. E24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0410462 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-4687 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200280836%22">00280836 </searchLink><i>NLM ISO Abbreviation: </i>Nature <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35864232
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41586-022-05103-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: E24
    Titles:
      – TitleFull: Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Collier DA
      – PersonEntity:
          Name:
            NameFull: De Marco A
      – PersonEntity:
          Name:
            NameFull: Ferreira IATM
      – PersonEntity:
          Name:
            NameFull: Meng B
      – PersonEntity:
          Name:
            NameFull: Datir RP
      – PersonEntity:
          Name:
            NameFull: Walls AC
      – PersonEntity:
          Name:
            NameFull: Kemp SA
      – PersonEntity:
          Name:
            NameFull: Bassi J
      – PersonEntity:
          Name:
            NameFull: Pinto D
      – PersonEntity:
          Name:
            NameFull: Silacci-Fregni C
      – PersonEntity:
          Name:
            NameFull: Bianchi S
      – PersonEntity:
          Name:
            NameFull: Tortorici MA
      – PersonEntity:
          Name:
            NameFull: Bowen J
      – PersonEntity:
          Name:
            NameFull: Culap K
      – PersonEntity:
          Name:
            NameFull: Jaconi S
      – PersonEntity:
          Name:
            NameFull: Cameroni E
      – PersonEntity:
          Name:
            NameFull: Snell G
      – PersonEntity:
          Name:
            NameFull: Pizzuto MS
      – PersonEntity:
          Name:
            NameFull: Pellanda AF
      – PersonEntity:
          Name:
            NameFull: Garzoni C
      – PersonEntity:
          Name:
            NameFull: Riva A
      – PersonEntity:
          Name:
            NameFull: Elmer A
      – PersonEntity:
          Name:
            NameFull: Kingston N
      – PersonEntity:
          Name:
            NameFull: Graves B
      – PersonEntity:
          Name:
            NameFull: McCoy LE
      – PersonEntity:
          Name:
            NameFull: Smith KGC
      – PersonEntity:
          Name:
            NameFull: Bradley JR
      – PersonEntity:
          Name:
            NameFull: Temperton N
      – PersonEntity:
          Name:
            NameFull: Ceron-Gutierrez L
      – PersonEntity:
          Name:
            NameFull: Barcenas-Morales G
      – PersonEntity:
          Name:
            NameFull: Harvey W
      – PersonEntity:
          Name:
            NameFull: Virgin HW
      – PersonEntity:
          Name:
            NameFull: Lanzavecchia A
      – PersonEntity:
          Name:
            NameFull: Piccoli L
      – PersonEntity:
          Name:
            NameFull: Doffinger R
      – PersonEntity:
          Name:
            NameFull: Wills M
      – PersonEntity:
          Name:
            NameFull: Veesler D
      – PersonEntity:
          Name:
            NameFull: Corti D
      – PersonEntity:
          Name:
            NameFull: Gupta RK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1476-4687
          Numbering:
            – Type: volume
              Value: 608
            – Type: issue
              Value: 7922
          Titles:
            – TitleFull: Nature
              Type: main
ResultId 1